Valuation SOPHiA GENETICS SA Börse Stuttgart
Stocks
90B
CH1125843347
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.000 EUR | +1.21% |
|
+3.73% | +28.87% |
| 07-01 | Sophia Genetics Insider Sold Shares Worth $506,690, According to a Recent SEC Filing | MT |
| 06-29 | Sophia Genetics Insider Sold Shares Worth $298,155, According to a Recent SEC Filing | MT |
Company Valuation: SOPHiA GENETICS SA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 900.4 | 132.3 | 306.8 | 204 | 316.8 | 476.5 | - | - |
| Change | - | -85.31% | 131.92% | -33.51% | 55.34% | 50.4% | - | - |
| Enterprise Value (EV) | 635.1 | -29.03 | 183.5 | 151.6 | 316.8 | 476.5 | 476.5 | 476.5 |
| Change | - | -104.57% | 732.16% | -17.4% | 109.03% | 50.4% | 0% | 0% |
| P/E | -10.6x | -1.51x | -3.86x | -3.23x | -3.99x | -6.26x | -8.17x | -12.6x |
| PBR | 3.27x | 0.66x | 2.03x | 2.13x | - | - | - | - |
| PEG | - | -0.67x | 0.4x | 0.1x | -0.2x | 0.3x | 0.3x | 0.4x |
| Capitalization / Revenue | 22.3x | 2.78x | 4.92x | 3.13x | 4.1x | 5.1x | 4.24x | 3.4x |
| EV / Revenue | 0x | -0x | 0x | 0x | 0x | 5.1x | 4.24x | 3.4x |
| EV / EBITDA | -0x | 0x | -0x | -0x | -0x | -14.6x | -22.2x | -59.9x |
| EV / EBIT | -0x | 0x | -0x | -0x | -0x | -7.88x | -10x | -14.7x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.33 | -1.36 | -1.22 | -0.95 | -1.17 | -0.9075 | -0.695 | -0.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 40.45 | 47.56 | 62.37 | 65.17 | 77.27 | 93.4 | 112.4 | 140.2 |
| EBITDA 1 | -67.88 | -82.25 | -66.49 | -57.97 | -41.5 | -32.73 | -21.44 | -7.95 |
| EBIT 1 | -71.49 | -87.82 | -74.83 | -66.57 | -70.91 | -60.46 | -47.63 | -32.45 |
| Net income 1 | -73.68 | -87.45 | -78.98 | -62.49 | -79 | -64.65 | -50.72 | -32.5 |
| Net Debt | -265.3 | -161.3 | -123.3 | -52.39 | - | - | - | - |
| Reference price 2 | 14.100 | 2.060 | 4.710 | 3.070 | 4.670 | 5.680 | 5.680 | 5.680 |
| Nbr of stocks (in thousands) | 63,858 | 64,211 | 65,132 | 66,439 | 67,847 | 83,895 | - | - |
| Announcement Date | 3/15/22 | 3/7/23 | 3/5/24 | 3/4/25 | 3/3/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 30.19x | 6.63x | 14.68x | -.--% | 31.37B | |
| 89.73x | 76.91x | 95.8x | 0.41% | 14.22B | |
| 83.74x | 12.36x | 53.66x | 0.7% | 5.7B | |
| -32x | 8.98x | -48.64x | - | 2.2B | |
| 58.9x | - | - | -.--% | 2.09B | |
| -6.21x | 61.81x | -6.26x | - | 1.82B | |
| -114.48x | - | - | - | 1.07B | |
| 6.29x | - | - | - | 911M | |
| 27.35x | 5.56x | 12.15x | 1.77% | 805M | |
| Average | 15.95x | 28.71x | 20.23x | 0.58% | 6.69B | |
| Weighted average by Cap. | 43.98x | 26.89x | 36.00x | 0.21% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- SOPH Stock
- 90B Stock
- Valuation SOPHiA GENETICS SA
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
